CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-18). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2761 · Search date 2026-08-18 · Methodology v0.7

Twenty-four-hour lying-flat head position,
does it really help with Reduced 90-day disability versus sitting up at 30 degrees or more?

30-Second Summary
D
Evidence Grade D · 34 · Safety acceptable
Twenty-four-hour lying-flat positioning did not improve 90-day disability, death, or pneumonia
Serious adverse events occurred in 14.3% versus 13.5%, and pneumonia in 3.1% versus 3.4%, without significant differences. Individual aspiration, respiratory, and intracranial-pressure considerations still require clinical judgment.
What the
research shows
The grade is D with 34 points. HeadPoST cluster-randomized 11,093 patients across 114 hospitals in a crossover design. Among 9,748 patients with the 90-day modified Rankin outcome, the common odds ratio was 1.01 (95% CI 0.92 to 1.10; P=.84). Lying flat did not improve the disability distribution, and mortality was 7.3% versus 7.4%.
What the
ads claim
A physiologic statement that lying flat may alter cerebral blood flow must not be expanded into improved 90-day function. The large clinical trial found no difference in disability, death, or pneumonia between the standardized positions.
*

Useful facts when choosing a product

  • The intervention was a 0-degree lying-flat position for at least 24 hours early after admission.
  • The comparator elevated the head to at least 30 degrees.
  • NCT02162017 and ACTRN12614000483651 are two registrations of the same trial.
Gap Measurement · Verdict 2761 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

A total of 5,295 patients were assigned to lying flat and 5,798 to sitting up; 90-day mRS data were available for 4,676 and 5,072, respectively. Serious adverse events occurred in 756/5,295 (14.3%) versus 784/5,798 (13.5%), and pneumonia in 164/5,295 (3.1%) versus 198/5,798 (3.4%). NHMRC grant 1066966 funded the trial. Author disclosures listed advisory, lecture, and travel relationships with Medtronic, AstraZeneca, Takeda, Boehringer Ingelheim, and others, but did not state that a company supplied a positioning intervention or an assessment tool used in this trial. Axis 6 B0 evidence ① Allocation concealment: "A statistician not otherwise involved in the trial will generate the randomised allocation sequence ... and the allocation sequence will be concealed until the interventions are assigned." ② Masking: "cluster-randomized, crossover, open-label trial with blinded outcome evaluation" — positioning could not be masked, while outcome evaluation was masked. ③ Analysis population and missing data: "We will analyse patients in the treatment group to which they are allocated according to the intention-to-treat principle." Multiple-imputation sensitivity analysis addressed missing 90-day outcomes. ④ Prespecified primary endpoint: "The primary outcome of death or disability according to the mRS score at 90 days" — consistent with registrations NCT02162017 and ACTRN12614000483651

02

Why this is classified as D (34)

The large publicly funded cluster trial used masked outcome evaluation and missing-data sensitivity analysis, but benefit on 90-day disability was null and only one confirmatory trial exists, giving D with 34 points.

Counterpoint. D does not deny that one position may be more comfortable or appropriate for an individual patient's aspiration or respiratory risk. It applies to the claim that the standardized 24-hour strategy improves overall 90-day disability.

Rejudgment record. Cross-check applied — Cross-checked the HeadPoST article, protocol, and both registrations for the cluster-crossover design, 90-day mRS, analyzed population, missing-data sensitivity analysis, NHMRC funding, and author disclosures

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Improved 90-day disability distributionDThe common OR was null at 1.01 (0.92 to 1.10).
Reduced 90-day mortalityDMortality was 7.3% versus 7.4%.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1International 114-hospital cluster-randomized crossover open-intervention trial with masked outcome evaluation5,072Australian NHMRC grant 1066966; no statement of company-supplied trial materials or assessment toolsDistribution of modified Rankin disability scores at 90 daysCommon OR 1.01 (95% CI 0.92 to 1.10), P=.84; mortality 7.3% versus 7.4%Null result from one large publicly funded confirmatory trial
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-18).

Anderson CS, Arima H, Lavados P, et al. Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke. N Engl J Med. 2017;376(25):2437-2447. PMID: 28636854. DOI: 10.1056/NEJMoa1615715. NCT02162017; ACTRN12614000483651.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-18 · Corrections: none

Cite this verdict

Twenty-four-hour lying-flat head position x 90-day disability after acute stroke Evidence Grade D card
[Chamgap] Twenty-four-hour lying-flat head position x 90-day disability after acute stroke — Evidence Grade D·34. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/cognition/lying-flat-head-position-acute-stroke-90-day-disability/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.